| MR编号 | IT/H/0114/001 |
|---|
| 药品名称 | VARIVAX |
|---|
| 活性成分 | - Varicella virus, live attenuated 1350.0 PFU
|
|---|
| 剂型 | Powder and solvent for suspension for injection |
|---|
| 上市许可持有人 | Sanofi Pasteur MSD S.p.A.
Via degli Aldobrandeschi, 15
00163 Roma ITALY |
|---|
| 参考成员国 - 产品名称 | Italy (IT) |
|---|
| 互认成员国 - 产品名称 | - Bulgaria (BG)
VARIVAX - Croatia (HR)
- Czechia (CZ)
Varivax - Iceland (IS)
- Poland (PL)
VARIVAX - Romania (RO)
Varivax pulbere și solvent pentru suspensie injectabilă - Latvia (LV)
- Germany (DE)
- Denmark (DK)
- Belgium (BE)
Varivax poudre et solvant pour suspension injectable - Netherlands (NL)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
VARIVAX Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension - France (FR)
- Spain (ES)
- Portugal (PT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Lithuania (LT)
- Estonia (EE)
- Hungary (HU)
- Cyprus (CY)
- Slovakia (SK)
- Slovenia (SI)
- Malta (MT)
|
|---|
| 许可日期 | 2003/07/09 |
|---|
| 最近更新日期 | 2025/07/23 |
|---|
| 药物ATC编码 | - J07BK01 varicella, live attenuated
| 申请类型 | - TypeLevel1：New Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Full Dossier Article 4.8 Di 65/65
- TypeLevel4：Biological: Vaccine
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|